IRIS UniCatt

De Candia, Erica
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 3.289
AS - Asia 2.679
EU - Europa 2.513
SA - Sud America 513
AF - Africa 78
OC - Oceania 17
Continente sconosciuto - Info sul continente non disponibili 4
Totale 9.093
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 3.202
SG - Singapore 1.267
CN - Cina 557
IT - Italia 459
DE - Germania 449
BR - Brasile 437
PL - Polonia 382
SE - Svezia 381
VN - Vietnam 246
FR - Francia 177
UA - Ucraina 142
IE - Irlanda 137
GB - Regno Unito 111
IN - India 102
ID - Indonesia 82
FI - Finlandia 79
JP - Giappone 79
BD - Bangladesh 67
HK - Hong Kong 57
RU - Federazione Russa 51
CA - Canada 42
MX - Messico 34
NL - Olanda 34
AR - Argentina 32
IQ - Iraq 32
TR - Turchia 31
AT - Austria 23
PK - Pakistan 21
IR - Iran 20
ZA - Sudafrica 20
BE - Belgio 19
KR - Corea 17
AU - Australia 16
EG - Egitto 16
EC - Ecuador 15
JO - Giordania 14
ES - Italia 12
HU - Ungheria 12
MA - Marocco 12
UZ - Uzbekistan 12
CH - Svizzera 10
MY - Malesia 9
RO - Romania 9
IL - Israele 8
PH - Filippine 8
SA - Arabia Saudita 8
VE - Venezuela 8
KE - Kenya 7
TN - Tunisia 7
AE - Emirati Arabi Uniti 6
BH - Bahrain 5
CL - Cile 5
LB - Libano 5
PY - Paraguay 5
CI - Costa d'Avorio 4
CZ - Repubblica Ceca 4
LT - Lituania 4
MK - Macedonia 4
NP - Nepal 4
SY - Repubblica araba siriana 4
UY - Uruguay 4
A2 - ???statistics.table.value.countryCode.A2??? 3
BO - Bolivia 3
DO - Repubblica Dominicana 3
ET - Etiopia 3
AL - Albania 2
AZ - Azerbaigian 2
BG - Bulgaria 2
CO - Colombia 2
CR - Costa Rica 2
DZ - Algeria 2
GE - Georgia 2
GT - Guatemala 2
KW - Kuwait 2
MN - Mongolia 2
NG - Nigeria 2
PE - Perù 2
PS - Palestinian Territory 2
AM - Armenia 1
BN - Brunei Darussalam 1
BZ - Belize 1
CG - Congo 1
CY - Cipro 1
DK - Danimarca 1
EE - Estonia 1
GA - Gabon 1
GI - Gibilterra 1
GR - Grecia 1
HR - Croazia 1
KZ - Kazakistan 1
LC - Santa Lucia 1
LK - Sri Lanka 1
LU - Lussemburgo 1
LV - Lettonia 1
MD - Moldavia 1
MG - Madagascar 1
ML - Mali 1
NZ - Nuova Zelanda 1
OM - Oman 1
PA - Panama 1
Totale 9.086
Salva come PNG Salva come JPEG
Città #
Singapore 754
Ashburn 389
Warsaw 374
Chandler 333
San Jose 297
Dublin 131
Beijing 117
Fairfield 106
San Mateo 90
Rome 88
Los Angeles 87
Wilmington 85
Ho Chi Minh City 82
Jakarta 72
New York 72
Jacksonville 70
Council Bluffs 67
Tokyo 67
Hanoi 66
Lauterbourg 66
Woodbridge 62
Hefei 60
Ann Arbor 59
Nanjing 59
Munich 56
Hong Kong 52
Seattle 51
Boston 49
Houston 49
Marseille 42
Milan 42
Chicago 39
Frankfurt am Main 39
Boardman 37
Moscow 36
Princeton 36
São Paulo 36
Dearborn 33
Dallas 32
The Dalles 32
Buffalo 30
Cambridge 28
Cattolica 28
Redwood City 28
Helsinki 25
Hyderabad 23
London 23
Lawrence 20
Nuremberg 20
Santa Clara 19
Nanchang 18
Rio de Janeiro 17
Brussels 16
Seoul 16
Tukwila 16
Da Nang 14
Turku 14
Augusta 13
Denver 13
Hangzhou 13
Kent 13
Redmond 13
Shanghai 13
Amman 12
Andover 12
Curitiba 12
Guangzhou 12
Lappeenranta 12
Nürnberg 12
Pune 12
St Louis 12
Bologna 11
Chennai 11
Izmir 11
Norwalk 11
San Diego 11
San Francisco 11
Baghdad 10
Bremen 10
Brooklyn 10
Budapest 10
Guarulhos 10
Montreal 10
Mountain View 10
Naples 10
Tashkent 10
Vienna 10
Zhengzhou 10
Bari 9
Brasília 9
Johannesburg 9
Paris 9
Verona 9
Washington 9
Atlanta 8
Belo Horizonte 8
Hebei 8
Phoenix 8
Salvador 8
Düsseldorf 7
Totale 5.120
Salva come PNG Salva come JPEG
Nome #
Abnormal proplatelet formation and emperipolesis in cultured human megakaryocytes from gray platelet syndrome patients 342
Bleeding risk of surgery and its prevention in patients with inherited platelet disorders. The Surgery in Platelet disorders And Therapeutic Approach (SPATA) study 277
Thromboelastography clot strength profiles and effect of systemic anticoagulation in COVID-19 acute respiratory distress syndrome: a prospective, observational study 221
Eltrombopag for the treatment of inherited thrombocytopenias: a phase 2 clinical trial 214
Data on the application of early coagulation support protocol in the management of major trauma patients 199
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 185
Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome 174
Murine platelet production is suppressed by S1P release in the hematopoietic niche, not facilitated by blood S1P sensing. 173
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 171
Noncanonical type 2B von Willebrand disease associated with mutations in the VWF D9D3 and D4 domains 171
COVID-19 and haemostasis: a position paper from Italian Society on Thrombosis and Haemostasis (SISET) 164
Effect of fibrinogen concentration on the velocity of platelet aggregation. 163
Safety of antithrombotic therapy in subjects with hereditary hemorrhagic telangiectasia: prospective data from a multidisciplinary working group 156
Platelets and Neurodegenerative Diseases: Current Knowledge and Future Perspectives 155
Nonalcoholic fatty liver disease (NAFLD) severity is associated to a nonhemostatic contribution and proinflammatory phenotype of platelets 153
Patients with antiphospholipid syndrome and a first venous or arterial thrombotic event: clinical characteristics, antibody profiles and estimate of the risk of recurrence 151
Autoimmune disorders of platelet function: systematic review of cases of acquired Glanzmann thrombasthenia and acquired delta storage pool disease 149
Does chronic oral anticoagulation reduce in-hospital mortality among COVID-19 older patients? 144
Functional role of protease activated receptors in vascular biology 143
Heparin induced thrombocytopenia: Position paper from the Italian Society on Thrombosis and Haemostasis (SISET) 141
Structural and funtional mapping of the thrombin domain involved in the binding to the platelet glycoprotein Ib 139
MORE EARLY BLEEDS ASSOCIATED WITH HIGH BASELINE DIRECT ORAL ANTICOAGULANT LEVELS IN ATRIAL FIBRILLATION: THE MAS STUDY 137
Mechanisms of platelet activation by thrombin: a short history 133
Detection of Platelet-Activating Antibodies Associated with Vaccine-Induced Thrombotic Thrombocytopenia by Flow Cytometry: An Italian Experience 133
Hemophilia A and von Willebrand deficiency: therapeutic implications 130
Direct oral anticoagulants and therapeutic adherence: do not let your guard down 130
Effects of unfractionated and low molecular weight heparins on platelet thromboxane biosynthesis "in vivo" 129
Consensus statements on vaccination in patients with haemophilia—Results from the Italian haemophilia and vaccinations (HEVA) project 129
MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations 127
Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk 122
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives 121
Carbamazepine interaction with direct oral anticoagulants: help from the laboratory for the personalized management of oral anticoagulant therapy 121
Evaluation of Novel Guanidino-Containing Isonipecotamide Inhibitors of Blood Coagulation Factors against SARS-CoV-2 Virus Infection 120
Antithrombotic prophylaxis for surgery-associated venous thromboembolism risk in patients with inherited platelet disorders. The SPATA-DVT Study 120
Early coagulation support protocol: A valid approach in real-life management of major trauma patients. Results from two Italian centres 119
Thrombotic events associated with low baseline direct oral anticoagulant levels in atrial fibrillations: the MAS study 117
Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders. 117
D-dimer and reduced-dose apixaban for extended treatment after unprovoked venous thromboembolism: the Apidulcis study 116
Lymph node blast crisis in chronic myeloid leukemia mimicking T-immunoblastic lymphoma. 114
Thrombin interaction with platelet GpIB: role of the heparin binding domain. 111
Thrombin-thrombomodulin interaction: energetics and potential role of water as an allosteric effector. 111
Allosteric equilibria in the binding reaction of fibrinogen to platelets. 111
Correlation between platelet phenotype and NBEAL2 genotype in patients with congenital thrombocytopenia and α-granule deficiency 108
Safety and effectiveness of oral anticoagulants in patients with atrial fibrillation and stage 4 chronic kidney disease: a real-world experience 107
Portal vein thrombosis occurrence in a cirrhotic patient during treatment with rivaroxaban 106
Gut Microbiome Diversity and Composition Correlates With Time in the Therapeutic Range in Patients on Warfarin Treatment: A Pilot Study 105
Extended coagulation profile of children with Long Covid: a prospective study 104
Association of laboratory test results with the bleeding history in patients with inherited platelet function disorders (the Bleeding Assesment Tool - LABoratory tests substudy): communication from the Platelet Physiology ISTH-SSC 102
The ISTH bleeding assessment tool as predictor of bleeding events in inherited platelet disorders: Communication from the ISTH SSC Subcommittee on Platelet Physiology 102
Hepatocellular carcinoma complicating liver cirrhosis in type IIIa glycogen storage disease. 101
Binding of human alpha-thrombin to platelet GpIb: energetics and functional effects. 99
Novel manifestations of immune dysregulation and granule defects in gray platelet syndrome 99
Ibrutinib does not affect ristocetin-induced platelet aggregation evaluated by light transmission aggregometry in chronic lymphocytic leukemia patients 96
Rituximab for treatment of autoimmune acquired platelet function disorders: description of two cases of acquired Glanzmann thrombasthenia and one case of acquired delta storage pool disease 96
Analysis of 339 pregnancies in 181 women with 13 different forms of inherited thrombocytopenia 94
NETosis in arterial and venous thrombosis: a one size fits all mechanism? 94
Circulating Activated Platelets in Children With Long Covid: A Case-Controlled Preliminary Observation 92
INHIBITION OF FIBRINOGEN BINDING TO HUMAN-PLATELETS BY BLOCKAGE OF NA+/H+ EXCHANGE. 88
MYH9-Related Disease: A Novel Prognostic Model to Predict the Clinical Evolution of the Disease Based on Genotype-Phenotype Correlations 88
Megakaryocytic emperipolesis and platelet function abnormalities in five patients with gray platelet syndrome 88
Bleeding and thrombotic events in a patient with lupus anticoagulant-associated hypoprothrombinemia and antiphospholipid antibody syndromes: managing hemostasis between Scylla and Charybdis 87
Platelet diameters in inherited thrombocytopenias: analysis of 376 patients with all known disorders 87
Association of human leucocyte antigen loci with vaccine-induced immune thrombotic thrombocytopenia: Potential role of the interaction between platelet factor 4-derived peptides and MHC-II 84
Management of bleeding and of invasive procedures in patients with platelet disorders and/or thrombocytopenia:Guidelines of the Italian Society for Haemostasis and Thrombosis (SISET) 80
Cell Surface Platelet Tissue Factor Expression: Regulation by P2Y12 and Link to Residual Platelet Reactivity 79
Defective platelet responsiveness to thrombin and protease-activated receptors agonists in a novel case of gray platelet syndrome: correlation between the platelet defect and the alpha-granule content in the patient and four relatives 77
Validation of the ISTH/SSC bleeding assessment tool for inherited platelet disorders: A communication from the Platelet Physiology SSC 76
Why the disorder induced by GATA1 Arg216Gln mutation should be called "X-linked thrombocytopenia with thalassemia" rather than "X-linked gray platelet syndrome 72
Protective effect of oral anticoagulant drugs in atrial fibrillation patients admitted for COVID-19: Results from the CORIST study 71
Binding of thrombin to glycoprotein Ib accelerates the hydrolysis of Par-1 on intact platelets 70
Prevalence and significance of anti-prothrombin (aPT) antibodies in patients with Lupus Anticoagulant (LA). 68
COVID-19 pandemic affects the ability of negative D-dimer to identify venous thromboembolism patients at low risk of recurrence: insights from the Apidulcis study 66
Atrial Fibrillation, Heart Failure Phenotypes, and Mortality Risk in the Nationwide START Registry: A Propensity Score Matching Analysis 53
Increased platelet-fibrinogen affinity in patients with myeloproliferative disorders 42
Long-term left ventricular thrombosis resolution in patients receiving vitamin k antagonists: a multicenter observational study 40
Impact of the 2023 ACR/EULAR Classification Criteria on START2 Antiphospholipid Registry 36
PO-54 - Clinical and laboratory characterization of platelet dysfunction caused by ibrutinib treatment in patients with chronic lymphocytic leukemia 16
Real-world use of direct oral anticoagulants in atrial fibrillation patients with moderate/severe chronic kidney disease: a propensity score matched analysis from the START registry 1
Early Platelet Dysfunction in Sepsis: An ICU Pilot Study 1
Multiple arterial thrombosis in a 33-year-old woman with anasarca, systemic lupus erythematosus, and acquired coagulopathy 1
Totale 9.229
Salva come PNG Salva come JPEG
Categoria #
all - tutte 38.466
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.466
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/202112 0 0 0 0 0 0 0 0 0 0 0 12
2021/2022658 44 82 22 39 34 18 18 111 23 39 112 116
2022/20231.048 141 135 71 141 85 126 74 84 129 12 33 17
2023/2024657 19 161 27 34 28 70 48 16 12 26 52 164
2024/20251.235 24 32 113 64 65 46 42 49 172 133 302 193
2025/20263.757 527 155 225 391 638 205 659 173 225 251 204 104
Totale 9.229